News Breaks |
|
|
| October 9, 2012 |
| 07:42 EDT |  | EW | Edwards Lifesciences weakness could create buying opportunity, says ThinkEquity
After Edwards Lifesciences preannounced lower than expected Q3 revenue, ThinkEquity believes the company's transcatheter revenues could rebound strongly in Q4 and 2013 if the FDA approves SAPIEN Cohort A labeling. The firm maintains a $121 target and Buy rating on the stock. |
|
|
News For EW From The Last 14 Days Check below for free stories on EW the last two weeks. |
|
|
| June 14, 2013 |
| 09:57 EDT | | EW | Court ruling a minor negative for Edwards Lifesciences, says Leerink
 Subscribe for More Information |
|
| 09:45 EDT | | EW | Edwards lost first of three cases against Medtronic, says Wells Fargo
Subscribe for More Information |
|
| 07:53 EDT |  | EW | Edwards loses patent bid in Germany versus Medtronic, Bloomberg says
A German court ruled that Edwards Lifescience's (EW) patent does not cover Medtronic's (MDT) product, Bloomberg reports. |
|
| June 11, 2013 |
| 07:31 EDT |  | EW | Goldman to host a conference
Subscribe for More Information |
|
| June 10, 2013 |
| 10:04 EDT |  | EW | On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alexandria Real Estate (ARE) upgraded to Buy from Neutral at ISI Group... BB&T (BBT) upgraded to Overweight from Equal Weight at Evercore... CyrusOne (CONE) upgraded to Strong Buy from Outperform at Raymond James... EQT Corporation (EQT) upgraded to Buy from Hold at Brean Capital... Edwards Lifesciences (EW) upgraded to Outperform from Neutral at Credit Suisse... Enersis (ENI) upgraded to Buy from Neutral at Citigroup... Entergy (ETR) upgraded to Buy from Hold at Deutsche Bank... Monsanto (MON) upgraded to Outperform from Neutral at Macquarie... Regency Centers (REG) upgraded to Buy from Neutral at ISI Group... Silver Standard (SSRI) upgraded to Hold from Sell at Deutsche Bank... Standard Pacific (SPF) upgraded to Neutral from Underweight at JPMorgan... Stericycle (SRCL) upgraded to Buy from Hold at Wunderlich... WABCO (WBC) upgraded to Buy from Neutral at Goldman... Western Union (WU) upgraded to Outperform from Market Perform at Raymond James... Weyerhaeuser (WY) upgraded to Outperform from Sector Perform at RBC Capital... Washington Trust Bancorp (WASH) upgraded to Buy from Hold at Sandler O'Neill... EastGroup Properties (EGP) upgraded to Buy from Hold at Sandler O'Neill... Valeant (VRX) upgraded to Buy from Fair Value at CRT Capital... RF Micro Devices (RFMD) upgraded to Strong Buy from Buy at Charter Equity... Bank of the Ozarks (OZRK) upgraded to Outperform from Market Perform at Raymond James... United Community Banks (UCBI) upgraded to Outperform at Raymond James... Western Union (WU) upgraded at Raymond James... CyrusOne (CONE) upgraded to at Raymond James... AT&T (T) upgraded to Buy from Hold at Argus... IMAX (IMAX) upgraded to Buy from Neutral at B. Riley... TriMas (TRS) upgraded to Outperform from Market Perform at Barrington. |
|
| 06:25 EDT | | EW | Edwards Lifesciences upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information |
|
| June 4, 2013 |
| 09:25 EDT | | EW | FDA posts warning letter to Edwards Lifesciences over plant inspections
Reference Link |
|
|
|
|
|
